Pre-Market Earnings Report for August 4, 2025 : IDXX, BNTX, ON, WAT, KSPI, TSN, CNA, W, BRKR, TGTX, TSEM, AXSM

The article details key analyst consensus expectations for several companies reporting Q2 2025 earnings on August 4, 2025, spanning sectors from medical instruments to semiconductors and biotech. For each firm, it provides the consensus earnings per share, anticipated year-over-year growth or decline, recent performance against prior estimates, and 2025 Price-to-Earnings ratios compared to their respective industry averages. This compilation offers investors a critical pre-earnings snapshot of anticipated financial performance and relative valuation metrics across a diverse set of companies.

Analysis

The upcoming earnings reports for August 4, 2025, reveal a highly divergent landscape across multiple sectors. In the biomedical and medical instruments space, TG Therapeutics (TGTX) stands out with a projected 700% year-over-year EPS increase, though its high forward P/E of 40.34 versus an industry average of 1.60 indicates that lofty growth expectations are already priced in; a significant short interest, reflected by over 16 days to cover, adds a layer of potential volatility. IDEXX Laboratories (IDXX) is also poised for strong growth with a 35.66% YoY EPS forecast, but this follows a notable miss of -14.98% in the prior year's corresponding quarter, setting a high bar for performance. Conversely, several companies face significant headwinds. ON Semiconductor (ON) is expected to report a sharp 43.75% YoY decline in EPS, creating a potential valuation conflict with its P/E of 24.61, which is substantially above its industry's 14.20. Similarly, Tyson Foods (TSN), CNA Financial (CNA), and Bruker (BRKR) are all forecasting YoY EPS declines of 17.24%, 21.01%, and 36.54%, respectively. BioNTech (BNTX) and Wayfair (W) are expected to continue posting losses, with consensus EPS at $-1.31 and $-0.27, and both have a recent history of substantial earnings misses, signaling ongoing fundamental challenges. A notable exception is Joint Stock Company Kaspi.kz (KSPI), which combines a strong 28.96% EPS growth forecast with a P/E ratio of 6.55, significantly below its industry's 18.50, suggesting a potential valuation discrepancy.

Key Decisions for Investors

• For high-growth, premium-valuation stocks like TGTX and IDXX, investors should focus on forward guidance, as any failure to meet elevated expectations could trigger a sharp price correction, with TGTX's high short interest adding potential for a short squeeze on a positive surprise.
• Caution is warranted for companies like ON Semiconductor, where a significant projected EPS decline of 43.75% appears misaligned with a premium P/E ratio, suggesting vulnerability to a downward re-rating if results confirm the negative trend.
• Monitor for potential value opportunities or risks in companies with conflicting signals, such as Kaspi.kz (KSPI), where strong growth is paired with a low relative valuation, and Tower Semiconductor (TSEM), where a history of large positive surprises could outweigh the projected EPS decline.
• In cases of persistent losses, such as BioNTech (BNTX) and Wayfair (W), investors should scrutinize any commentary on the path to profitability, as their recent large earnings misses make them high-risk holdings without a clear turnaround narrative.